Multivalent, Asymmetric IL-2–FC Fusions Show Enhanced Selectivity for Regulatory T Cells

Scientists profiled the dynamics and dose dependency of signaling responses in primary human immune cells induced by engineered fusions composed of either wild-type IL-2 or mutant forms with altered affinity, valency, and fusion to the antibody Fc region for stability.